Genprex Announced That Its Research Collaborators Presented Positive Preclinical Data And Research From Studies Of GPX-002, Diabetes Gene Therapy Drug Candidate, In An Oral Presentation At The American Society Of Gene And Cell Therapy's 28Th Annual Meetin